Retinal Vasospasm-Induced Central Retinal Artery Occlusion and the Possible Role for Hyperbaric Oxygen Treatment

Affiliations

¹ Department of Ophthalmology and Visual Neurosciences (AVN, HVM, ASA), University of Minnesota, Minneapolis, Minnesota; Department of Ophthalmology (ASA), Hennepin Healthcare, Minneapolis, Minnesota; and Retina Consultants of Minnesota (JBD), Minneapolis, Minnesota.

Ameay V Naravane et al. J Neuroophthalmol. 2024.

. 2024 Dec 1;44(4):e581-e582.

doi: 10.1097/WNO.0000000000002028. Epub 2023 Nov 6.

¹ Department of Ophthalmology and Visual Neurosciences (AVN, HVM, ASA), University of Minnesota, Minneapolis, Minnesota; Department of Ophthalmology (ASA), Hennepin Healthcare, Minneapolis, Minnesota; and Retina Consultants of Minnesota (JBD), Minneapolis, Minnesota.

No abstract available

Conflict of interest statement

The authors report no conflicts of interest.

1. Mishulin AM, Gandhi S, Apple D, Lin X, Hu J, Abrams GW. Inducible transient central retinal artery vasospasm: a case report. Retin Cases Brief Rep. 2020;14:178–180.
1. Carroll D. Retinal migraine. Headache. 1970;10:9–13.
1. Winterkorn J, Kupersmith MJ, Wirtschafter JD, Forman S. Brief report: treatment of vasospastic amaurosis fugax with calcium-channel blockers. N Engl J Med. 1993;329:396–398.
1. Pournaras JA, Nguyen C, Mameletzi E, Zografos L, Wolfensberger TJ. Successful treatment of longstanding vasospastic central retinal artery occlusion. Acta Ophthalmol. 2010;88:e34–e35.